IDO1 and multiple sclerosis: In the meantime, Lemos and colleagues (2014) identified that systemic DNA nanoparticle (DNP) treatment in mice model of multiple sclerosis inhibited the progression and severity of experimental autoimmune encephalitis (EAE) via the STING/IFN-αβ/IDO pathway [77].